Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arginine and Tissue Plasminogen Activator

Research Papers that Mention the Interaction

The interaction between rtPA and L-arginine may be leading to the production of nitric oxide, which can cause direct neurotoxicity, altered cerebral blood flow, and disruption of the neurovascular unit.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism  •  2010  |  View Paper
Pretreating the samples with arginine decreased or abolished immunofluorescence staining for PAI-1 and t-PA , but not for VN.
Journal of the American Society of Nephrology : JASN  •  1996  |  View Paper
Results After exposing the cultured mouse retinal cells to tPA plus L-arginine or L-arginine alone, cyclic-GMP concentrations were 61.9 ± 5.1 pmole/mL and 63.1 ± 6.1 pmole/mL, respectively.
Korean journal of ophthalmology : KJO  •  2012  |  View Paper
l-Arginine seems to be the major factor in retinal toxicity of commercial tPA (containing l-arginine).
Current eye research  •  2005  |  View Paper
Thrombolysis with use of tPA coupled with L-arg resulted in an increase in EDR (95% +/- 4.9; ACh = 15 micro g/min; n = 5; P =.007).
Journal of vascular and interventional radiology : JVIR  •  2003  |  View Paper